関連する実験動画
Updated: Sep 8, 2025

08:52
Chemical Dimerization-Induced Protein Condensates on Telomeres
Published on: April 12, 2021
3.2K
細胞機能と癌における生物分子の凝縮物の役割
Herencia-Lagunar Elena1, Carrera-Bravo Claudia1, Castano Enrique2
1Laboratory of Cancer Cell Architecture, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Advances in biological regulation
|September 6, 2025
まとめ
生物分子凝縮物 (BMC) は,生化学反応の組織化に不可欠な動的細胞部位である. これらの構造の調節不良は病気に関連しており,治療開発のためにその形成を理解する必要性を強調しています.
科学分野:
- 細胞生物学
- 生物化学
- バイオ物理学
背景:
- 生物分子凝縮物 (BMC) は,液体-液体相分離によって形成される膜のない器官である.
- 細胞の機能を調整し 特定の生物分子を集中させ 反応速度を高めます
- 例としては,正常な生理学にとって不可欠な核球とカジャール体があります.
研究 の 目的:
- 生物分子の凝縮生物生成を制御する分子原理を探求する.
- 病原性におけるコンデンサート不調の役割を理解する.
- コンデンサートダイナミクスを調節するための治療標的を特定する.
主な方法:
- 骨組みとクライアント分子間の多価相互作用の分析
- 段階分離における本質的に無秩序な領域の役割を調査する.
- コンデンサに関連したタンパク質の病気に関連した変異を調べる.
主要な成果:
- マルチバレントの相互作用は,BMCの形成と機能を駆動する.
- 本質的に乱れた領域と特定の変異は,病理的な相分離につながる可能性があります.
- 異常なBMCは神経変性疾患,癌,免疫疾患に 関与しています.
結論:
- BMCのバイオゲネシスを理解することは 新しい病気の治療法の開発の鍵です
- コンデンサートダイナミクスを調節することで 治療の戦略が生まれます
- 細胞生物学と医学をさらに発展させるでしょう
関連する概念動画
Condensins
3.6K
Condensins are large protein complexes that use ATP to fuel the assembly of chromosomes during mitosis. They transform the tangled, shapeless mass of post-interphase DNA into individualized chromosomes by compacting, organizing, and segregating chromosomal DNA.
The plant and animal cells contain two types of condensin complexes—condensin I and condensin II. Both complexes have five subunits: two SMC (Structural Maintenance of Chromosomes) subunits, a kleisin subunit, and two HEAT-repeat...
The plant and animal cells contain two types of condensin complexes—condensin I and condensin II. Both complexes have five subunits: two SMC (Structural Maintenance of Chromosomes) subunits, a kleisin subunit, and two HEAT-repeat...
3.6K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
What is Cancer?
11.1K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
11.1K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K

